I am a Cancer Cell Biologist and Immunologist with primary experience in patient-derived models of cancer (PDMCs) and clinical informatics. I currently oversee generation, validation and drug-response assays of PDMCs including cell lines, 3D models with cell lines, organoids, and patient-derived xenografts for OHSU's participation in a U01 Consortium on Patient-Derived Models of Cancer. I additionally focus on clinical case studies of patients with exceptionally positive outcomes after diagnosis with pancreatic adenocarcinoma. To facilitate these research interests, I have created and maintain a database that connects specimen- and PDMC-level results (e.g., gene-expression-based subtypes, genomic alterations, leukocyte densities, drug responses, etc) with robust clinical data I have collected and curated from patients with pancreatic adenocarcinoma. This database has allowed our group to identify relationships between newly-defined clinical cohorts, outcomes, and disease characteristics. Research Interests: Pancreatic Cancer, Lymphoma, PDXs, Organoids, Cell Lines, Patient-Dervied Models of Cancer, Drug Discovery, MYC-Mediated Oncogenesis, Cancer Cell Biology, Immunology, Tumor Immunity, Autoimmunity, Cell Metabolism